GENESYS.NSGENESYS.NSNSE
Loading
EBITDA Margin Over TimeContracting
Percentile Rank73
3Y CAGR+4.5%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
+4.5%/yr
vs +17.1%/yr prior
Acceleration
-12.7pp
Decelerating
Percentile
P73
Within normal range
vs 3Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM40.99%-13.0%
202547.10%+8.3%
202443.49%+20.9%
202335.97%+393.7%
2022-12.24%+70.1%
2021-40.93%-352.7%
202016.20%-15.2%
201919.10%-39.5%
201831.58%+25.6%
201725.15%-